Viewing Newborn Screening movie
BehavioralNBS Movie and printed brochure were viewed by the participants
NCT Number: NCT02676245
To address the content, timing, efficacy, and impact of prenatal education about newborn screening generally and sample retention specifically.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
It is widely recognized that new parents receive insufficient information about newborn screening (NBS) and little or no information regarding the retention of residual newborn screening samples. Our current research (R01 HD058854) clearly demonstrates that parents are supportive of NBS and the research use of residual specimens, but they want information before the child is born and want an informed choice regarding the retention and use of residual samples. Previous research has outlined the basic elements of what parents want to know about NBS generally. However, given that many states are adopting an "opt-out" approach for residual samples, it is unclear what basic information parents want to know to enable an informed choice about this practice. While it is recognized that retention and use of residual NBS samples is a valuable research resource, there are prevalent concerns in the NBS community that discussion of this will lead some parents to decline NBS altogether. Some authorities have suggested that discussions of NBS and residual sample retention be conducted separately to reduce the risk that parents will confuse the issues and decline NBS altogether.
To address this the project has the following specific aims:
Specific Aim 1) To determine what pregnant women, young mothers, and their partners want to know regarding the retention and use of residual bloodspot samples
Specific Aim 2) To create multimedia educational tools to be used in the prenatal care environment that will provide basic information about NBS and the core information determined through Specific Aim 1 about residual sample retention and use.
Specific Aim 3) To determine the impact of the prenatal education intervention on parental knowledge, attitudes, and decisions regarding NBS services and the retention and use of residual samples in diverse populations of English and Spanish speaking pregnant women.
Specific Aim 4) To examine the normative/ethical implications of the results of SA3 for the conduct of state NBS programs. Recommendations on the content and timing of parental NBS education will be developed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NBS Movie and printed brochure were viewed by the participants
DBS Movie and and printed brochure were viewed by the participants
Time frame: 2-4 weeks after due date
Knowledge of key items about newborn screening that were conveyed in the educational interventions
Time frame: 2-4 weeks after due date
Knowledge of key items about newborn dried blood spots that were conveyed in the educational interventions
Time frame: 2-4 weeks after due date
Knowledge of newborn screening
Time frame: 2-4 weeks after due date
Knowledge of newborn dried blood spots
Time frame: 2-4 weeks after due date
Attitudes regarding support for newborn screening
Time frame: 2-4 weeks after due date
Attitudes regarding support for newborn dried blood spots
Time frame: 2-4 weeks after due date
Parents choice about newborn screening
Time frame: 2-4 weeks after due date
Parents choice about dried bloodspot retention
University of Utah
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06058910
Brain Diseases, Brain Diseases, Metabolic
Kettering, Ohio, United States
View Trial DetailsNCT02590328
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03141307
Neonatal Screening
Lansing, Michigan, United States
View Trial DetailsNCT02374281
Neonatal Screening, Neurologic Manifestations
Saint-Etienne, France
View Trial Details